The switch from apoptosis to pyroptosis potentially bypasses antiapoptotic obstacles and overcomes chemoresistance; thus, appropriate induction of GSDME-mediated pyroptosis is a primary issue in cancer treatment. This evidence concerns the gene GSDME and cancer.